Status:
COMPLETED
Topic Ketorolac Added to Panphotocoagulation in Proliferative Diabetic Retinopathy
Lead Sponsor:
Hospital Juarez de Mexico
Conditions:
Proliferative Diabetic Retinopathy
Macular Edema
Eligibility:
All Genders
40-75 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to determine the efficacy and safety of topic ketorolac in treatment for center point thickness secondary to panphotocoagulation in proliferative diabetic retinopathy.
Detailed Description
Panphotocoagulation is the standard treatment for proliferative diabetic retinopathy during 3 to 4 sessions within 2 weeks. This treatment reduces the incidence of severe visual loss in the long term....
Eligibility Criteria
Inclusion
- type 2 diabetes
- proliferative diabetic retinopathy
- without macular edema
- adequate quality 6 mm fast macular map on the day of treatment
- visual capacity under subjective refraction before treatment
- signed of inform consent
Exclusion
- ocular surgery in the last 4 months
- myopia over -6.00 diopters
- allergy to ketorolac or non-steroids antiinflammatory
- previous selective photocoagulation
- using non-steroids antiinflammatory or immunomodulators
- intraocular inflammatory
- any retinal disease different from diabetic retinopathy
- pregnancy
- actual corneal disease
- inadequate quality 6 mm fast macular map after the second visit
- inconsistency after the second visit
- adverse event of the drug
- remove of the inform consent
Key Trial Info
Start Date :
June 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2015
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT00907114
Start Date
June 1 2009
End Date
March 1 2015
Last Update
March 20 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Virgilio Lima Gomez
Mexico City, Mexico City, Mexico, 07760